ArticleActa neuropathologica communications2026
PCK2 as a potential therapeutic target for aggressive MYC-amplified non-WNT/non-SHH medulloblastoma based on tumor continuum.
Shuaishuai Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.